MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)
$20.36 0.43 (2.1576%)
Analysed MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) News Sources
Why Is MLTX Stock Rallying Nearly 20% Overnight?
22-06-2026
stocktwits.com
MoonLake Immunotherapeutics Announces Proposed Public Offering
22-06-2026
yahoo.com
MLTX Stock Clocks Best Day In Over 6 Months — What’s Driving The Investor Optimism?
22-06-2026
stocktwits.com
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
24-06-2026
yahoo.com
MLTX Stock Extends Pullback After Biggest Rally In Over 6 Months Following Skin Disease Trial Data — A Look At The Latest Development
24-06-2026
stocktwits.com
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid Easing US-Iran Tensions
24-06-2026
yahoo.com
Why MoonLake Immunotherapeutics Stock Wilted on Wednesday
25-06-2026
fool.com
How Investors May Respond To MoonLake Immunotherapeutics (MLTX) VELA Data And Upsized Follow-On Offering
25-06-2026
yahoo.com
MoonLake Immunotherapeutics (MLTX) Outlook Strengthens as Analysts See Major Opportunity in Hidradenitis Suppurativa
30-06-2026
yahoo.com
MoonLake Immunotherapeutics' CFO Sells 39K Shares
03-07-2026
fool.com
What is the current price of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)?
The current price of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) is $20.36.
MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) since the previous trading day is $0.43.
MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) since the previous trading day is 2.1576%.
What is the most recent average sentiment score for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)?
The most recent average sentiment score for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)?
The most recent sentiment for MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ) is .
SEC-8K** Filing Available For MOONLAKE IMMUNOTHERAPEUTICS (MLTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.